Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA Says Its Safety Review of Abortion Pill Will Continue Into Next Year

(MedPage Today) -- The FDA says its ongoing safety review of mifepristone, the nation's main abortion pill, will continue into next year, a timeline that was quickly condemned by abortion opponents hoping to see the drug's use curtailed. The FDA...

FDA Says Its Safety Review of Abortion Pill Will Continue Into Next Year

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at medpagetoday.com →

More in Health & Medicine

Early-onset cancer rising worldwide: Causes, risk, prevention

Across Latin America, early-onset cancer rates have risen, but Chile and Brazil have seen the fastest growth, especially with bowel, breast and cervical cancers. But it is a worldwide trend.

  • Early-onset cancer cases worldwide are rising, with some rates doubling in 20 years
  • Colorectal cancer among under-50s doubled in England from 2001 to 2023
  • Experts advise healthy weight, regular exercise, fiber intake to lower cancer risk

More from Thursday 8 October →